The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance

Metabolism: Clinical and Experimental

Volumn 46, Issue 4, 1997, Pages 395-399

  Chiu, Ken C ^a   McCarthy, Jennifer E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME BLOOD LEVEL; FEMALE; GENE INSERTION; GENE LOCUS; GENETIC POLYMORPHISM; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL;

EID: 0030901112     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90054-8     Document Type: Article

References (40)

1. Soubrier F, Hubert C, Testut P, et al: Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene. J Hypertens 11:471-476, 1993
2. Ehlers MRW, Riordan JF: Angiotensin-converting enzyme: New concepts concerning its biological role. Biochemistry 28:5311-5318, 1989
3. Alhenc-Gelas F, Courbon D, Warnet JM, et al: Distribution of plasma angiotensin I-converting enzyme levels in healthy men: Relationship to environmental and hormonal parameters. J Lab Clin Med 117:33-39, 1991
4. Rigat B, Hubert C, Alhenc-Gelas F, et al: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
5. Soubrier F, Wei L, Hubert C, et al: Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications. J Hypertens 11:599-604, 1993
6. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
7. Ruiz J, Blanche H, Cohen N, et al: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:3662-3665, 1994
8. Lieberman J, Nosal A, Schlesser LA, et al: Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. Am Rev Respir Dis 120:329-335, 1979
9. Lieberman J, Sastre A: Serum angiotensin-converting enzyme: Elevations in diabetes mellitus. Ann Intern Med 93:825-826, 1980
10. Ninimiya Y, Arakawa M: Serum angiotensin-converting enzyme activity in type 2 (non-insulin-dependent) diabetic patients with chronic glomerulonephritis. Diabetes Res 11:121-124, 1989
11. Migdalis IN, Iliopoulou V, Kalogeropoulou K, et al: Elevated serum levels of angiotensin-converting enzyme in patients with diabetic retinopathy. South Med J 83:425-427, 1990
12. Letizia C, Repossi P, Sellini M, et al: Serum angiotensin converting enzyme in diabetic retinopathy. Int J Tissue React 14:299-305, 1992
13. Feman SS, Mericle RA, Reed GW, et al: Serum angiotensin converting enzyme in diabetic patients. Am J Med Sci 305:280-284, 1993
14. Marre M, Bernadet P, Gallois Y, et al: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
15. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy, evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43:690-695, 1994
16. Jandrain B, Herbaut C, Depoorter J-C, et al: Long-term accept-ability of perindopril in type II diabetic patients with hypertension. Am J Med 92:91S-94S, (suppl 4B) 1992
17. Bergemann R, Wohler D, Weidmann P, et al: Verbesserte glucoseeinstellung und mikro-albuminurie/proteinurie bei diabetikern unter ACE-hemmer-behandlung. Schweiz Med Wochenschr 122:1369-1376, 1992
18. Jauch K-W, Hartl W, Guenther B, et al: Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 17:448-454, 1987
19. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-873, 1989
20. Allemann Y, Baumann S, Jost M, et al: Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril. Eur J Clin Pharmacol 42:275-280, 1992
21. Raffel LJ, Robbins DC, Norris JM, et al: The GENNID Study: A resource for mapping the genes that cause NIDDM. Diabetes Care 19:864-872, 1996
22. Chiu KC, McCarthy JE: Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 221:614-618, 1996
23. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E233, 1979
24. Chiu KC, Province MA, Permutt MA: Glucokinase gene is genetic marker for NIDDM in American blacks. Diabetes 41:843-849, 1992
25. Fogarty DG, Maxwell AP, Doherty CC, et al: ACE gene typing. Lancet 343:851, 1994
26. Odawara M, Matsunuma A, Yamashita K: A pitfall in the association study of ACE gene polymorphism. Diabetes Care 19:543-544, 1996
27. Lindpaintner K, Lee M, Larson M, et al: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 334:1023-1028, 1996
28. Reynolds MV, Bristow MR, Bush EW, et al: Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 342:1073-1075, 1993
29. Marian AJ, Yu Q-T, Workman R, et al: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342:1085-1086, 1993
30. Matthew DR, Hosker JP, Rudenski AS, et al: Homeostatic model assessment: Insulin resistance and β-cell function from fasting glucose and insulin concentration in men. Diabetologia 28:412-419, 1985
31. Panahloo A, Andres C, Mohamed-Ali V, et al: The insertion allele of the ACE gene I/D polymorphism, a candidate gene for insulin resistance? Circulation 92:3390-3393, 1991
32. Townsend RR, DiPette D: Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men. Am J Physiol 265:E362-E366, 1993
33. Buchanan TA, Thawani H, Kade W, et al: Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest 92:720-726, 1993
34. Widgren BR, Urbananvicius V, Wikstrand J, et al: Low-dose angiotensin II increases glucose deposition rate during euglycemic hyperinsulinemia. Am J Hypertens 6:892-895, 1993
35. Morris AD, Petrie J, Ueda S, et al: Angiotensin II increases insulin sensitivity in non-insulin dependent diabetes: Dissociation of metabolic and blood pressure effects. Diabetes 43:1445-1449, 1994
36. Smrck AV, Helper JR, Brown KO, et al: Regulation of polyphos-phoinositide specific phospholipase C activity by purified Gq. Science 251:804-807, 1991
37. 2+ sensitive protein kinases in the response of hepatocytes to angiotensin II and vasopressin. J Biol Chem 259:3283-3292, 1984
38. Considine RV, Caro JF: Protein kinase C: Mediator or inhibitor of insulin action? J Cell Biochem 52:8-13, 1993
39. Donnelly R, Reed MJ, Azhar S, et al: Expression of the major isozyme of protein kinase C in skeletal muscle, PKC-θ, varies with fiber-type composition and in response to fructose induced insulin resistance. Endocrinology 135:2369-2374, 1994
40. Morris AD, Donnelly R: Angiotensin II: An insulin-sensitizing vasoactive hormone? J Clin Endocrinol Metab 81:1303-1306, 1996